학술논문

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Document Type
Journal
Source
LANCET; JUN 23 2012, 379 9834, p2352-p2363, 12p.
Subject
Language
English
ISSN
01406736